Heart medication study for cancer survivors with mild heart weakness
Treatments studied
Part of Heart & circulation clinical trials.
This study tests a heart medication (sacubitril/valsartan) in young cancer survivors whose hearts were weakened by anthracycline chemotherapy but are not yet having heart failure symptoms. It aims to see if the drug can improve heart function and prevent future problems.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You were 39 or younger when diagnosed with cancer.
- You had a type of chemotherapy called anthracycline.
- Your heart's squeeze strength is mildly reduced but not severely (ejection fraction between 40% and normal, or heart strain less than 18%).
- You do not have symptoms of heart failure (like shortness of breath, fatigue, or swelling).
- You are not currently taking certain blood pressure or pain medicines that can't be stopped for the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests sacubitril/valsartan to help prevent heart weakness (cardiotoxicity) caused by breast cancer treatments like anthracyclines and/or anti-HER2 drugs. If you qualify, you may be offered this heart-protection medicine while your cancer is treated.
This trial tests a medicine called sacubitril-valsartan for people in rural Tanzania with heart failure and reduced pumping strength. It aims to see if switching to this drug can improve symptoms and outcomes.
This trial tests whether a personalized, risk-based heart care plan can help prevent heart failure in people who had certain cancer treatments. It focuses on monitoring and guiding treatment, using heart ultrasound results and other health factors.
This study tests a structured heart rehabilitation program for people who have had cancer treatment. It aims to improve heart health and reduce cardiovascular problems in cancer survivors.
This study tests a new tool that helps doctors figure out your risk for heart problems after cancer treatment. If you join, you'll get a heart risk check and possibly see a heart specialist. This could help prevent heart issues later.
This trial tests a structured lifestyle and exercise change program for young people who finished cancer treatment and have signs of early heart weakness. The goal is to improve heart health and lower the chance of heart failure later.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.